Tim Pryce

HUDSON, MA -- (MARKET WIRE) -- 09/04/2003 -- Chase-Walton Elastomers, a leading designer, developer and fabricator of silicone elastomer components, has promoted Tim Pryce, former COO, to President.As President of Chase-Walton and SF Medical, a wholly owned division of Chase-Walton Elastomers, Pryce will execute the company's strategic plan of extending its reach in aerospace and in becoming the leading provider of quality silicone products in the biomedical and pharmaceutical markets.
...
"Through the combination of Tim's engineering background, extensive international experience, hands-on knowledge of our product lines in both Europe and the U.S and his keen understanding of our market drivers, Tim will lead Chase-Walton to achieving its goal of becoming the premier international silicone company for its targeted markets."

Pryce joined Chase-Walton in 1994 as the European Sales Director to establish a sales and distribution outlet based in his native London and to build the export business of Chase-Walton Elastomers, the parent company.In 1996, he was then offered a position with Chase-Walton Elastomers, as VP Sales and Marketing and relocated to the U.S. Pryce was instrumental in increasing the revenue twofold while at the same time, successfully establishing a state of the art silicone facility for SF Medical to focus on the production of silicone components for the biomedical and pharmaceutical industries.In 2002, as COO Pryce made significant changes in the direction of the company by repositioning it for further growth in its main markets of aerospace, industrial applications, biomedical and pharmaceutical.

Early in his career, Pryce valued the importance of excellent customer service while at Rolls-Royce PLC where he was a Product Support Engineer and actively worked with customers in the field to resolve technical and commercial opportunities.This further supports Chase-Walton's dedication and loyalty to its customers due to being customer-centric and ensuring customers a positive experience.

Tim Pryce stated, "I am delighted to assume this role and looking forward to the opportunities that lie ahead.

"We've grown extensively over the last few years and the business has been extremely successful," said Chase-Walton's president, Tim Pryce, who will keep his position within the organization."Really, where we want to take this company, we needed to continue to invest in the business in a substantial manner....We had to be acquired by a large corporation."

Pryce said the company realized $15 million in revenue last year and expects a 15 percent sales increase this year and next, partly due to the resources it will gain from Trelleborg.

Pryce said Chase-Walton employees and customers are excited about the growth opportunities the takeover gives the company, which does 80 percent of its business in North America.He said customers can expect no disruptions in service.

"Paul brings to the company more than 25 years of manufacturing experience in the production of medical devices, pharmaceutical packaging and bio-pharmaceutical devices," said Tim Pryce, President of Chase-Walton.

According to Tim Pryce, President of Chase-Walton, "Paul brings to the company more than 25 years of manufacturing experience in the production of pharmaceutical and biotech solutions.
...
"With this focus on technology and engineering, we can provide extraordinary levels of customer satisfaction," Pryce added.

Chase-Walton Elastomers, a designer, developer and fabricator of silicone elastomer components, has promoted Tim Pryce, former COO, to President.As President of Chase-Walton and SF Medical, a wholly-owned division of Chase-Walton Elastomers, Pryce will execute the company's strategic plan of extending its reach in aerospace and in becoming the leading provider of quality silicone products in the biomedical and pharmaceutical markets.
...
"Through the combination of Tim's engineering background, extensive international experience, hands-on knowledge of our product lines in both Europe and the U.S and his keen understanding of our market drivers, Tim will lead Chase-Walton to achieving its goal of becoming the premier international silicone company for its targeted markets."

Pryce joined Chase-Walton in 1994 as the European Sales Director to establish a sales and distribution outlet based in his native London and to build the export business of Chase-Walton Elastomers, the parent company.In 1996, he was then offered a position with Chase-Walton Elastomers, as VP Sales and Marketing and relocated to the U.S. Pryce was instrumental in increasing the revenue twofold while at the same time, successfully establishing a state of the art silicone facility for SF Medical to focus on the production of silicone components for the biomedical and pharmaceutical industries.In 2002, as COO Pryce made significant changes in the direction of the company by repositioning it for further growth in its main markets of aerospace, industrial applications, biomedical and pharmaceutical.Early in his career, Pryce valued the importance of excellent customer service while at Rolls-Royce PLC where he was a Product Support Engineer and actively worked with customers in the field to resolve technical and commercial opportunities.

Tim Pryce stated, "I am delighted to assume this role and looking forward to the opportunities that lie ahead.